Diamedica therapeutics inc. (DMAC)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities:
Net loss

-2,425

-2,480

-2,448

-2,469

-3,252

-1,962

-1,387

-1,735

-650

Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation

393

401

451

182

130

65

110

292

153

Amortization of discount on marketable securities

14

6

15

27

26

-

-

-

-

Non-cash lease expense

13

13

12

12

12

-

-

-

-

Depreciation

6

5

5

5

6

5

4

2

4

Change in fair value of warrant liability

-

-

-

-

-

0

0

0

39

Changes in operating assets and liabilities:
Amounts receivable

162

159

-448

182

150

-263

721

-467

709

Prepaid expenses

290

-42

-109

-99

-72

209

50

62

-13

Deposits

107

-

-

-

-

-

-

-

-

Accounts payable

262

-130

50

-422

201

234

-203

-31

-30

Accrued liabilities

-654

227

195

-69

-127

-296

409

44

245

Net cash used in operating activities

-2,978

-1,865

-1,232

-2,871

-3,134

-1,900

-1,838

-1,023

-935

Cash flows from investing activities:
Purchase of marketable securities

8,799

1,991

0

0

10,928

-

-

-

-

Maturities of marketable securities

3,500

-

-

-

-

-

-

-

-

Purchase of property and equipment

2

-

-

-

-

-13

21

10

32

Net cash used in investing activities

-5,301

1,008

3,000

3,012

-10,928

13

-21

-10

-32

Cash flows from financing activities:
Proceeds from issuance of common shares, net of offering costs

7,682

-

-

-

-

-

-

-

-

Proceeds from the exercise of stock options

16

-

-

-

-

-

-

-

-

Principal payments on finance lease obligations

2

1

1

1

2

-

-

-

-

Proceeds from issuance of common shares and warrants, net offering costs

-

-

-

-

-

0

0

0

5,840

Proceeds from the exercise of common share purchase warrants

-

-

-

-

-

86

31

6

484

Net cash provided by financing activities

7,696

-1

-1

74

-2

14,812

31

49

6,324

Net decrease in cash and cash equivalents

-583

-858

1,767

215

-14,064

12,925

-1,828

-984

5,357